HOME Top Market Reports Vaccine Market - By Technology & Types, Trend Analysis By Various Classes - Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dentritic Vaccines And By Indications - Infectious Diseases, Cancer, Allergy, Diabetes, Cardiovascular Disease With Market Landscape Analysis - Global Forecasts To 2022

Vaccine Market - By Technology & Types, Trend Analysis By Various Classes - Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dentritic Vaccines And By Indications - Infectious Diseases, Cancer, Allergy, Diabetes, Cardiovascular Disease With Market Landscape Analysis - Global Forecasts To 2022

By: marketsandmarkets.com
Publishing Date: August 2013
Report Code: MD 2020

 

  Speak to Analyst Enquiry Before Buying
Analyst Briefing  
purchase report
download pdf  request for customisation


The vaccine technology market is an established segment and is widely accepted as an indispensable division of the healthcare industry. It is poised to grow rapidly by addressing the following: emerging infectious agents, various types of cancer, allergies, cardiovascular diseases, diabetes, smoke cessation, and neurodegenerative disorders. The global vaccine market is estimated at $32.05 billion in 2013 and is expected to reach $84.44 billion by 2022.

In general, the vaccine technology market is largely perceived negatively as a low-profit venture owing to the domination of top five companies, namely, Sanofi (France), Glaxo Smithkline (U.K.), Merck (U.S.), Pfizer (U.S.), and Novartis (Switzerland). Furthermore, a strong patent portfolio and the need for large investments towards vaccine development have limited the scope of entry for new companies.

The vaccine technology market is analyzed both in terms of qualitative (technological) and quantitative (revenue) perspectives. The technological analysis includes a discussion on different classes of vaccines, vaccine adjuvants, and commercially available products. The market revenue analysis includes market segmentation and the expected market position by 2022, with the projected growth rate.

The vaccine market is classified by technology class, types, end users, disease indication, and geography. The details on the emerging approaches to vaccine development such as reverse vaccinology, personalized vaccinomics, and systems vaccinomics are discussed. Furthermore, key research centers, with their critical areas of research in the vaccine space, have been provided.

An overview of regulations across various geographical regions has been covered. The complete value chain of the vaccine market is schematically represented and the significance of each stakeholder has been briefed.

Apart from the technological and market analysis, the investor climate has been assessed by tracking the complete investor network and collecting data on funds/grants and investments made towards vaccine development. Insights on current and future technological investment trends have also been discussed.

A large number of potential therapeutic and preventive vaccine candidates addressing various diseases which are in the pipeline are listed with their current status in clinical trials.
The adoption and developmental potential of the vaccine technology market has been discussed on a geographic basis, namely, North America, Europe, Asia, and the Rest of the World, by taking select countries that are poised to have a greater market value during the forecast period.

In brief, this research report provides:

  1. A detailed description of the global technology developments and evolving trends in the vaccine field with key prominence on research innovations, collaborative efforts, and investments for vaccines.
  2. A close view on the therapeutic vaccines for various diseases by providing details and status of current vaccines in the pipeline.
  3. An impact analysis of the major drivers and restraints influencing the adoption and growth of the vaccine market during the period of 2013 to 2022.
  4. Porters five forces analysis and GAP analysis.
  5. The global market forecast for 2013 - 2022, including demand side analysis and strategic recommendations for technology/product developers.
  6. Competitive landscape tracking industry activities such as mergers, acquisitions, partnerships, collaborations, and strategic agreements within the vaccine market. Intellectual property strength analysis based on the number of patents filed by the top five players within the vaccine market that gives an insight into prominent activities and global leaders of the industry.

Scope of the Report

This research report categorizes the global vaccine market into technology class, types, end users, disease indication, and geography. Each segment is further broken down by geography, with exhaustive revenue analysis for 2012 and 2013, as well as the forecast up to 2022.

Global Vaccine Market, by Technology Class

  • Live
  • Toxoid
  • Conjugate
  • Sub-Unit
  • Recombinant Vector Vaccines
  • DNA Vaccines
  • Synthetic Vaccines
  • Dentritic Vaccines

Global Vaccine Market, by Types

  • Preventive
  • Therapeutic

Global Vaccine Market, by End Users

  • Pediatric
  • Adult

Global Vaccine Market, by Disease Indication

  • Infectious Diseases
  • Cancer
  • Allergies
  • Others

Global Vaccine Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table Of Contents

1 Introduction (Page No. - 19)     
  1.1 Key Take-Aways    
  1.2 Report Scope    
  1.3 Report Segmentation    
  1.4 Research Methodology    
  1.5 Key Data Points From Secondary And Primary Sources    
  1.6 Logical Assumptions In This Study Based On Reliable Sources    
      
2 Executive Summary (Page No. - 26)     
      
3 Technology Snapshot (Page No. - 31)     
  3.1 Technology – Introduction     
  3.2 Technology – Evolution    
  3.3 Technology Segmentation    
  3.4 Technology Trends – By Class    
       3.4.1 Adjuvants   
  3.5 Key Vaccine Products In The Market    
  3.6 Technology Roadmap    
      
4 Vaccine Research Portfolio (Page No. - 42)     
  4.1 Global Research Portfolio – Research And Development Network    
  4.2 Emerging Approaches To Vaccine Developments    
  4.3 Key Research Centres    

5 Value Chain Analysis (Page No. - 47)     
  5.1 Overview    
  5.2 Cold Chain Management    
  5.3 Key Stakeholders    
  5.4 Gap Analysis    
  5.5 Porters Five Force Analysis   
      
6 Market Landscape (Page No. - 57)      
  6.1 Global Vaccine Technologies Market, Global Forecasts (2013 – 2022)    
      6.1.1 Global Vaccine Technologies Market, By Geography, 2012 – 2022    
      6.1.2 Vaccine Technologies Market Segmentation   
      6.1.3 Market Dynamics   
            6.1.3.1 Drivers  
            6.1.3.2 Restraints  
            6.1.3.3 Opportunities, Threats And Challenges  
  6.2 Global Vaccine Technologies Market, By End-User, 2012-2022    
      6.2.1 Global Vaccine Technologies Market Share, By End-User, 2012 – 2022    
      6.2.2 Paedriatic Vaccine Market, By Geography   
      6.2.3 Global Paedriatic Vaccine Market Share, By Geography   
      6.2.4 Global Adult Vaccine Market, By Geography   
      6.2.5 Global Adult Vaccine Market Share, By Geography   
  6.3 Global Vaccine Technologies Market, By Type, 2012-2022    
      6.3.1 Global Vaccine Technologies Market Share, By Type, 2012-2022   
      6.3.2 Global Preventive Vaccine Market, By Geography, 2012 – 2022    
      6.3.3 Global Preventive Vaccine Market Share, By Geography, 2012-2022   
      6.3.4 Global Therapeutic Vaccine Market, By Geography, 2012 – 2022    
      6.3.5 Global Therapeutic Vaccine Market Share, By Geography, 2012 – 2022    
  6.4 Global Vaccine Technologies Market, By Class, 2012 – 2022     
      6.4.1 Global Vaccine Technologies Market Share, By Class, 2012-2022   
      6.4.2 Live/Attenuated Vaccine  Market, By Geography   
            6.4.2.1 Live/ Attenuated Vaccine Market Share, By Geography  
      6.4.3 Toxoid Vaccine Market, By Geography   
            6.4.3.1 Toxoid Vaccine Market Share, By Geography  
      6.4.4 Conjugate Vaccine Market, By Geography   
            6.4.4.1 Conjugate Vaccine Market Share, By Geography  
      6.4.5 Sub-Unit Vaccine  Market, By Geography   
      6.4.6 Recombinant Vector Vaccine  Market, By Geography, 2012 – 2022    
      6.4.7 Dna Vaccine  Market, By Geography, 2012 – 2022    
      6.4.8 Synthetic Vaccine  Market, By Geography, 2012 – 2022    
            6.4.8.1 Synthetic Vaccine Market Share, By Geography, 2012 – 2022   
      6.4.9 Dentritic Vaccine Market, By Geography, 2012 – 2022    
  6.5 Vaccine Technology Market, By Disease Indication (2012 - 2022)    
      6.5.1 Infectious Disease Vaccine Market, By Geography   
      6.5.2 Cancer Vaccine Market, By Geography   
      6.5.3 Allergy Vaccine Market, By Geography   
      6.5.4 Others Vaccine Market, By Geography,  2012 – 2022    
      6.5.5 Others Potential Market, By Geography,  2016 – 2022    
      
7 Technology Adoption (Page No. - 110)     
  7.1 Factors That Drive Adoption Of Vaccine Technologies (Demand And Supply Side Analysis)    
  7.2 North America – U.S. & Canada    
  7.3 Europe – U.K, Germany, France, Italy    
  7.4 Asia – China, India    
  7.5 RoW – Australia & Africa    
      
8 Investment Analysis (Page No. - 122)     
  8.1 Investor Network    
  8.2 Investment Funding Analysis    
  8.3 Top Funding Organizations    
      
9 Competitive Landscape (Page No. - 126)     
  9.1 Competitive Landscape Analysis – Overview     
  9.2 Key Acquisitions/Partnerships/Agreements/Collaborations (2012 – 2013)    
  9.3 Vaccine Candidates In Pipeline – Allergy     
  9.4 Vaccine Candidates In Pipeline – Cancer     
  9.5 Vaccine Candidates In Pipeline – Infectious Diseases    
  9.6 Vaccine Candidates In Pipeline – Others     
      
10 Regulatory Landscape (Page No. - 135)   
   10.1 Regulatory Landscape – Overview     
   10.2 Regulations – Geographic     
      
11 Patent Analysis (Page No. - 140)     
   11.1 Patent Analysis – Overview     
   11.2 Patent Analysis By Company    
      
12 Analyst Recommendations (Page No. - 143)     
   12.1 Introduction    
   12.2 Technology Management Strategies    
      
13 Company Profiles (Page No. - 146)     
   13.1 Novartis AG    
   13.2 Glaxo Smithkline PLC   
   13.3 Merck & CO., INC.    
   13.4 Sanofi     
   13.5 Pfizer, INC.    
   13.6 Antigen Express, INC.    
   13.7 Aduro Biotech    
   13.8 Genticel    
   13.9 Biondvax Pharmaceuticals LTD   
   13.10 Immune Targeting Systems (ITS)    
   13.11 Prokarium    
   13.12 Immunobiology LTD    
   13.13 Liquidia Technologies    
   13.14 Alphavax    
   13.15 Bavarian Nordic    
      
14 Appendix (Page No. - 177)     
     Inter-Country Comparison Of Mortality For Selected Cause Of Death    
      
      
List Of Tables (22 Tables)     

      
Table 1 Vaccine Technologies Market, By Geography, 2012 – 2022 ($Billion)     
Table 2 Global Vaccine Technologies Market, By End-User, 2012 – 2022 ($Billion)      
Table 3 Paedriatic Vaccine Technology Market, By Geography, 2012 – 2022 ($Billion)      
Table 4 Adult Vaccine Technology Market, By Geography, 2012 – 2022 ($Billion)      
Table 5 Global Vaccine Technologies Market, By Type, 2012 – 2022 ($Billion)     
Table 6 Global Preventive Vaccine Technology Market, By Geography, 2012 – 2022 ( $Billion)     
Table 7 Therapeutic Vaccine Technology Market, By Geography, 2012 – 2022 ($Billion)     
Table 8 Global Vaccine Technologies Market, By Technology Class, 2012 – 2022 ($Billion)     
Table 9 Global Live Vaccine technology Market, By Geography, 2012-2022 ($Billion)     
Table 10 Toxoid Vaccine Market, By Geography, 2012 – 2022 ($Billion)     
Table 11 Conjugate Vaccine Market, By Geography, 2012 – 2022 ($Billion)     
Table 12 Subunit Vaccine Technology Market, By Geography, 2012 – 2022 ($Billion)     
Table 13 Recombinant Vector  Vaccine Market, By Geography, 2012 – 2022 ($Billion)     
Table 14 Dna Vaccine Market, By Geography,  2012 – 2022 ($Billion)     
Table 15 Synthetic Vaccine Technology Market, By Geography, 2012 – 2022      
Table 16 Dentritic Vaccine Technology Market, By Geography, 2017 – 2022 ($Billion)     
Table 17 Global Vaccine Technology Market, By Disease Indication, 2012 – 2022 ($Billion)     
Table 18 Infectious Disease Vaccine Market, By Geography, 2012 – 2022 ($Billion)     
Table 19 Cancer Vaccine Technology Market, By Geography, 2012 – 2022 ($Billion)     
Table 20 Allergy Vaccine Technology Market, By Geography, 2012 – 2022 ($Billion)     
Table 21 Others (Cardiovascular Disease, Diabetes, Smoke Cessation) Potential Market,By Geography, 2016 – 2022 ($Billion)     
Table 22 Revenue Of Top 5 Companies     
      

List Of Figures (53 Figures)      
       
      
Figure 1 Global Vaccine Technology Market, 2007 – 2012 ($Billion)     
Figure 2 Global Vaccine Technologies Market,2012 – 2022 ($Billion)     
Figure 3 Porter’s Value Chain Analysis     
Figure 4 Global Vaccine Technology Market, 2007 – 2012 ($Billion)     
Figure 5 Global Vaccine Technologies Market, 2013 – 2022 ($Billion)     
Figure 6 Vaccine Technologies Market, By Geography, 2012 – 2022 ($Billion)     
Figure 7 Vaccine Technologies Market Share, By Geography, 2012 – 2022     
Figure 8 Global Vaccine Technologies Market, By End-User, 2012 – 2022 ($Billion)     
Figure 9 Global Vaccine Technologies Market Share, By End-User, 2012 – 2022      
Figure 10 Paedriatic Vaccine Technology Market, By Geography, 2012 – 2022     
Figure 11 Paedriatic Vaccine Technology Market Share, By Geography, 2012 – 2022     
Figure 12 Adult Vaccine Technology Market, By Geography, 2012 – 2022       
Figure 13 Adult Vaccine Technology Market Share, By Geography, 2012 – 2022     
Figure 14 Global Vaccine Technologies Market, By Type, 2012 – 2022      
Figure 15 Global Vaccine Technologies Market Share, By Type, 2012 – 2022      
Figure 16 Preventive Vaccine Technology Market, By Geography, 2012 – 2022      
Figure 17 Preventive Vaccine Technology Market Share, By Geography, 2012 – 2022      
Figure 18 Therapeutic Vaccine Technology Market, By Geography, 2012 – 2022      
Figure19 Therapeutic Vaccine Technology Market Share,  By Geography, 2012 – 2022      
Figure 20 Global Vaccine Technologies Market, By Technology Class, 2012 – 2022 ($Billion)     
Figure 21 Global Vaccine Technologies Market Share, By Class, 2012 - 2022     
Figure 22 Live/Attenuated Vaccine Technology Market, By Geography, 2012 – 2022      
Figure 23 Live/Attenuated Vaccine Technology Market Share, By Geography, 2012 – 2022      
Figure 24 Toxoid Vaccine Technology Market, By Geography, 2012 – 2022      
Figure 25 Toxoid Vaccine Technology Market Share, By Geography, 2012 – 2022      
Figure 26 Conjugate Vaccine Technology Market, By Geography, 2012 – 2022      
Figure 27 Conjugate Vaccine Technology Market Share, By Geography, 2012 – 2022      
Figure 28 Subunit Vaccine Market, By Geography, 2012 – 2022 ($Billion)     
Figure 29 Sub-Unit Vaccine Market, By Geography, 2012 – 2022      
Figure 30 Recombinant Vector  Vaccine Market, By Geography, 2012-2022     
Figure 31 Recombinant Vector Vaccine Market Share, By Geography, 2012 – 2022      
Figure 32 Dna Vaccine Technology Market, By Geography,  2012 – 2022 ($Billion)     
Figure 33 Dna Vaccine Market, By Geography, 2012 – 2022      
Figure 34 Synthetic Vaccine Technology Market, By Geography, 2012 – 2022      
Figure 35 Synthetic Vaccine Technology Market Share, By Geography, 2012 – 2022      
Figure 36 Dentritic Vaccines, By Geography, 2012 – 2022      
Figure 37 Dentritic Vaccine Technology Market Share, By Geography, 2012 – 2022      
Figure 38 Global Vaccine Technology Market, By Disease Indication, 2012 – 2022      
Figure 39 Global Vaccine Technology Market Share, By Disease Indication, 2012 – 2022      
Figure 40 Infectious Disease Vaccine Technology Market, By Geography, 2012 – 2022      
Figure 41 Infectious Disease Vaccine Technology Market Share, By Geography, 2012 – 2022      
Figure 42 Cancer Vaccine Technology Market, By Geography, 2012 – 2022 ($Billion)     
Figure 43 Cancer Vaccine Technology Market, By Geography, 2012 – 2022     
Figure 44 Allergy Vaccine Technology Market, By Geography, 2012 – 2022      
Figure 45 Allergy Vaccine Technology Market Share, By Geography, 2012 – 2022      
Figure 46 Others (Cardiovascular Disease, Diabetes, Smoke Cessation) Potential Market,By Geography, 2016 – 2022 ($Billion)      
Figure 47 Others (Cardiovascular Disease, Diabetes, Smoke Cessation) Potential Market,By Geography, 2016 – 2022      
Figure 48 Global Vaccine Technologies Market,By Geography, 2012 – 2022      
Figure 49 Vaccine- Investor Network     
Figure 50 Global Vaccine Market Share,By Key Player, 2013     
Figure 51 Regulatory Approval Process     
Figure 52 Total Patents Filed Between 2008 – 2013      
Figure 53 Patent Analysis By Companies (2008 – 2012)      

The global vaccine technology market is anticipated to reach around $84 billion by 2022, growing at a CAGR of 11.36%. The vaccine market is divided by technology class (Live/Attenuated, Toxoid, Conjugate, Sub-Unit, Recombinant Vector, DNA, Synthetic, and Dentritic Vaccines), types (Preventive and Therapeutic), end users (Pediatric and Adult), disease indication (Infectious Diseases, Cancer, Allergies, and Others – Diabetes, Cardiovascular Diseases), and geography (North America, Europe, Asia, and Rest of the World). Furthermore, each technology class, type, end user, and disease indication segment is broken down by geography, with exhaustive revenue analysis for the entire forecast period. Of the above mentioned disease indication segments, infectious disease vaccines are the largest revenue segment; however, cancer vaccines will be the fastest-growing segment with the highest CAGR.

The potential growth of the vaccine technology market is attributed towards therapeutic vaccines, allergy vaccines, and emerging-disease vaccines. Improved understanding of immunology, new technological breakthroughs in the development of a new class of vaccines, namely, recombinant vector vaccines, DNA vaccines, and dendritic vaccines coupled with excellent distribution channels are propelling the growth of this market. Furthermore, a large population base in emerging economies and a high prevalence of diseases is driving the market, which is expected to remain consistent in the coming years. Largely popular as the biological preparation exclusively for the prevention of diseases, vaccines are now emerging as therapeutic agents for improving the immune system. This is adding a new dimension to the vaccine industry, opening doors for the treatment of various ailments, especially cancer, cardiovascular disease, diabetes, and smoke cessation. These opportunities have also paved the way for the entry of new companies and for the development of newer technology platforms. Furthermore, new emerging approaches to vaccine development such as reverse vaccinology, personalized vaccinomics, and systems vaccinomics are paving the way for the development of new effective vaccines capable of addressing current and emerging infectious diseases and cancers.

North America (42%) is a significant contributor, followed by Europe (36%), due to the highly structured healthcare reimbursement policies and the high purchasing power of costly vaccines. The new markets for vaccine are expected to grow at a vigorous pace in emerging economies such as China, India, and other regions in Asia-Pacific and untapped markets in Europe due to their growing GDP, healthcare costs, and rising demand for safe and cost-effective diagnostics and therapeutics.

The key players in this market are Novartis (Switzerland), Glaxo Smithkline (U.K.), Merck (U.S.), Sanofi (France), Pfizer (U.S.), Antigen Express, Inc. (U.S.), Aduro Biotech (U.S.), Genticel (France), Biondvax (Israel), Immune Targeting Systems (U.K.), Prokarium (U.K.), Immunobiology Ltd. (U.K.), Liquidia Technologies (U.S.), Alphavax (U.S.), and Bavarian Nordic (Denmark).

Vaccine Market

GLOBAL VACCINE TECHNOLOGIES MARKET 2013 - 2022 ($BILLIOIN)

Source: Expert Interviews, Annual Reports, Secondary Research Data, MarketsandMarkets Analysis

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports